Abdelhak, Ahmed http://orcid.org/0000-0001-9731-4169
Foschi, Matteo http://orcid.org/0000-0002-0321-7155
Abu-Rumeileh, Samir
Yue, John K.
D’Anna, Lucio
Huss, Andre
Oeckl, Patrick http://orcid.org/0000-0002-7652-7023
Ludolph, Albert C.
Kuhle, Jens
Petzold, Axel http://orcid.org/0000-0002-0344-9749
Manley, Geoffrey T.
Green, Ari J.
Otto, Markus http://orcid.org/0000-0003-4273-4267
Tumani, Hayrettin http://orcid.org/0000-0002-1647-6201
Article History
Accepted: 21 December 2021
First Online: 3 February 2022
Competing interests
: A.A. received research grants from the German Multiple Sclerosis Society (DMSG). P.O. received research support from the Michael J. Fox Foundation for Parkinson´s Research (grant ID MJFF-010349) and Alzheimer Forschung Initiative e.V. (20059CB). J.K. received speaker fees, research support, travel support and/or served on advisory boards of the Swiss MS Society, Swiss National Research Foundation (320030_189140/1), University of Basel, Progressive MS Alliance, Bayer, Biogen, Celgene, Merck, Novartis, Roche and Sanofi. G.T.M. reports funding from the US Department of Defense – TBI Endpoints Development Initiative (grant #W81XWH-14-2-0176), TRACK-TBI Precision Medicine (grant #W81XWH-18-2-0042), TRACK-TBI NETWORK (grant #W81XWH-15-9-0001), NIH-NINDS – TRACK-TBI (grant #U01NS086090), National Football League (NFL) Scientific Advisory Board, with support from the NFL for the research efforts of TRACK-TBI NETWORK. In addition, the US Department of Energy supports G.T.M. for a precision medicine collaboration, Abbott Laboratories has provided funding for TRACK-TBI clinical studies, NeuroTrauma Sciences LLC has provided funding to support TRACK-TBI data curation efforts, One Mind has provided funding for TRACK-TBI patients stipends and support to clinical sites. J.K.Y. received funding from NIH-NINDS – TRACK-TBI (grant #U01NS086090). A.J.G. reports personal fees from Bionure, Mylan, Neurona and Viela Bio; other support from Pipeline Therapeutics; and grants and other support from Inception Sciences outside the submitted work. M.O. gave scientific advice to Axon, Biogen Idec, Fujirebio and Roche. H.T. reports funding for research projects, lectures and travel from Bayer, Biogen, Genzyme, Merck Serono, Novartis, Roche and Teva, and received research support from DMSG and the German Ministry for Education and Research (BMBF). No other disclosures are reported.
Free to read: This content has been made available to all.